Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04754217 · ClinicalTrials.gov registry record
Valved Graft PMCF Study
A clinical trial of Aortic Valve Disease and Aortic Dissection, sponsored by Abbott Medical Devices.
- Recruiting
- Registry status
- 260
- Enrollment target
- 20
- Study locations
NCT04754217: Recruiting study of Aortic Valve Disease and Aortic Dissection, sponsored by Abbott Medical Devices.
NCT04754217 is a study of Aortic Valve Disease and Aortic Dissection that is actively recruiting participants, run by Abbott Medical Devices. The registered enrollment target is 260 participants, below the 18,600-participant average among 15 other Aortic Valve Disease trials with a reported enrollment target (99% lower). The trial reports 20 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04754217, a study of Aortic Valve Disease and Aortic Dissection, is actively recruiting participants, sponsored by Abbott Medical Devices.
- RECRUITING
- Registry status
- 260 participants
- Enrollment target
- 20
- Study locations
Study Summary
Multicenter, global, prospective, non-randomized, interventional, post-market trial. All subjects enrolled will receive an Abbott Valved Graft device.
Primary Outcome
Primary Safety Endpoint
Conditions Studied
Interventions
- DEVICE VAVGJ
- DEVICE CAVGJ
Study Locations (20)
Other
- Klinik Floridsdorf - Vienna
- Rigshospitalet - Copenhagen
- CHU de Besancon - Jean Minjoz - Besançon
- CHRU Lille - Lille
- Groupe Hospitalier Bichat - Claude Bernard - Paris
- Herz-und Diabetes Zentrum NRW - Bad Oeynhausen
- Deutsches Herzzentrum Berlin - Berlin
- Klinikum Links der Weser - Bremen
- Medizinische Hochschule Hannover - Hanover
- Onassis Cardiac Surgery Center - Athens
- Policlinico S.Orsola-Malpighi - Bologna
- Ospedale San Raffaele - Milan
- Policlinico San Donato - San Donato Milanese
- Wojewodzki Szpital Zespolony w Kielcach - Kielce
- Krakowski Szpital Specjalistyczny im. Jana Pawla II - Krakow
Pennsylvania
- Hospital of the University of Pennsylvania - Philadelphia
- University of Pittsburgh Medical Center - Pittsburgh
Alabama
- University Hospital - Univ. of Alabama at Birmingham (UAB) - Birmingham
Michigan
- University of Michigan - Ann Arbor
North Carolina
- Mission Health & Hospitals - Asheville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 260 participants |
| Start Date | 2021-07-13 |
| Est. Completion | 2029-09 |
What NCT04754217 shows while recruiting
NCT04754217 is an observational study that tracks outcomes without assigning an intervention. The registered 260 participants enrollment target is mid-sized for trials with a published cap, below the 18,600-participant average among 15 other Aortic Valve Disease trials with a reported enrollment target (99% lower).
The record links to 3 conditions, with Aortic Valve Disease appearing as the primary indexed condition, and to 2 interventions - of which VAVGJ is the first listed.
NCT04754217 names 20 study sites across 5 states, led by Other, Pennsylvania, Alabama.
Frequently Asked Questions
What is clinical trial NCT04754217 about?
NCT04754217 is a clinical study titled "Valved Graft PMCF Study". Multicenter, global, prospective, non-randomized, interventional, post-market trial. All subjects enrolled will receive an Abbott Valved Graft device.
What is the current status of trial NCT04754217?
This trial is currently recruiting. The enrollment target is 260 participants. The study started on 2021-07-13. Estimated completion is 2029-09.
What conditions does trial NCT04754217 study?
This clinical trial studies the following conditions: Aortic Valve Disease, Aortic Dissection, Ascending Aorta Abnormality.
What interventions are being tested in trial NCT04754217?
The interventions under investigation include: VAVGJ (DEVICE), CAVGJ (DEVICE).
Who is sponsoring clinical trial NCT04754217?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04754217 being conducted?
This trial has 20 study locations across Alabama, Michigan, North Carolina, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Aortic Valve Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04754217's enrollment target sits among peer trials
260 5th of 15 higher than 11 of 15 other Aortic Valve Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Aortic Valve Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The JenaValve ALIGN-AR LVAD Registry
RECRUITING · NA
-
Quantification of Debris Captured Using TCEP During VIV TAVR With BVF
RECRUITING · NA
-
CardioHeartConnect: Commercially Available Fitness for Cardiac Rehabilitation
RECRUITING · NA
-
Prospective Long-Term Outcomes of a Standardized Ross Procedure
RECRUITING
-
SJM Masters HP 15mm Rotatable Mechanical Heart Valve as Aortic Valve Replacement Therapy
ACTIVE NOT RECRUITING
-
Avalus Ultra Post-Approval Study (PAS)
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02283996 · 260 participants · Phase 4
Adhesive Capsulitis: Prospective Analysis of Efficacy and Financial Impact for Use of Physical Therapy in Treatment
- NCT03276793 · 260 participants · NA
Brain Connectivity in Depression
- NCT03407469 · 260 participants
Measurement of Adherence and Health-Related Quality of Life, and Health-Care Resource Utilization
- NCT03713125 · 260 participants · NA
Executive Function in Early Childhood
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI